Vertex Pharmaceuticals
VRTX
$400.34
Share price
-1.13%
Change (1 day)
20.28%
Change (1 year)
Categories
Operating Margin for Vertex Pharmaceuticals (VRTX)
Operating Margin as of April 2024 (TTM): 47.39%
According to Vertex Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 47.39%. At the end of 2022 the company had an Operating Margin of 47.39%.
Operating Margin history for Vertex Pharmaceuticals from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 47.39% | 31.47% |
| 2021 | 36.05% | -28.23% |
| 2020 | 50.22% | 49.88% |
| 2019 | 33.51% | 70.13% |
| 2018 | 19.70% | -3224.19% |
| 2017 | -0.63% | -84.07% |
| 2016 | -3.96% | -92.7% |
| 2015 | -54.21% | -57.19% |
| 2014 | -126.61% | 57.21% |
| 2013 | -80.54% | 9833.53% |
| 2012 | -0.81% | -118.92% |
| 2011 | 4.28% | -100.81% |
| 2010 | -526.35% | -9.29% |
| 2009 | -580.25% | 122.16% |
| 2008 | -261.18% | 25.96% |
| 2007 | -207.36% | 99.05% |
| 2006 | -104.17% | 18.25% |
| 2005 | -88.10% | -34.06% |
| 2004 | -133.60% | -46.51% |
| 2003 | -249.78% | 236.41% |
| 2002 | -74.25% | 82.48% |
| 2001 | -40.69% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -51.72% | 🇺🇸 USA |
 AbbVie ABBV | 18.65% | -60.65% | 🇺🇸 USA |
 Gilead Sciences GILD | 26.84% | -43.36% | 🇺🇸 USA |
 Merck MRK | 27.73% | -41.49% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | -59.40% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | -158.97% | -435.45% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.